Arrowhead Pharmaceuticals, Inc.
ARWR NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 4, 2026
ET
EPS Est.
-1.28
EPS Actual
-1.36
Revenue Est.
$44.2M
Revenue Actual
$75.3M
Next Earnings Report
Date
Nov 24, 2026 · Tue
ET Nov 24, 2026 · Tue
Time
11/24 21:00-11/25 01:00
After-market(ET)
Fiscal Period
FY2026 Q4
EPS Est.
-1.59
Revenue Est.
$59.2M
Company Overview
Arrowhead Pharmaceuticals, Inc. (ticker ARWR) is listed on NASDAQ with a market cap of about $9.04B. Its next earnings report (FY2026 Q4) is expected on Nov 24, 2026 (ET), After-market, with consensus EPS of -1.59. In the last 15 reported quarters, EPS beat consensus estimates 3 times.
Actual EPS TrendRecently15Term · Feb 6, 2023 → Aug 4, 2026
Feb 6, 2023Range: -1.39 ~ 2.75Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -1.28 | Below forecast↓-1.36 | $44.2M | $75.3M |
| May 7, 2026 | -- | -1.09 | Above forecast↑-0.93 | $73.8M | $73.7M |
| Feb 5, 2026 | -- | 0.60 | Below forecast↓0.22 | $213.9M | $264M |
| Nov 25, 2025 | -- | -0.11 | Below forecast↓-0.18 | $175.3M | $256.5M |
| Aug 7, 2025 | -- | -0.94 | Below forecast↓-1.26 | $154.1M | $27.8M |
| May 12, 2025 | -- | -0.06 | Above forecast↑2.75 | $116.3M | $542.7M |
| Feb 10, 2025 | -- | -0.42 | Below forecast↓-1.39 | $19.1M | $2.5M |
| Nov 26, 2024 | -- | -1.05 | Below forecast↓-1.38 | $55.1M | $3.6M |
| Aug 8, 2024 | -- | -0.58 | Below forecast↓-1.38 | $69.7M | -- |
| May 9, 2024 | -- | -0.06 | Below forecast↓-1.02 | $63.9M | -- |
| Feb 6, 2024 | -- | -0.78 | Below forecast↓-1.24 | $29.5M | $3.6M |
| Nov 29, 2023 | -- | -0.70 | Below forecast↓-1.03 | $50.7M | $16.1M |
| Aug 7, 2023 | -- | -0.58 | Below forecast↓-0.96 | $59.8M | $15.8M |
| May 2, 2023 | -- | -0.64 | Above forecast↑0.45 | $45.5M | $146.3M |
| Feb 6, 2023 | -- | 1.14 | Below forecast↓-0.39 | $162.5M | $62.5M |
Original Filings (SEC)
Earnings Release8-K · 2026-08-04 ↗
Quarterly10-Q · 2026-08-04 ↗
Quarterly10-Q · 2026-05-07 ↗
Earnings Release8-K · 2026-05-07 ↗
Quarterly10-Q · 2026-02-05 ↗
Earnings Release8-K · 2026-02-05 ↗
Annual10-K · 2025-11-25 ↗
Earnings Release8-K · 2025-11-25 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
